協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/11/21 | 1,130 | 1,145 | 1,120 | 1,145 | +21 | +1.9% | 1,649,000 |
2013/11/20 | 1,120 | 1,128 | 1,112 | 1,124 | +16 | +1.4% | 1,837,000 |
2013/11/19 | 1,100 | 1,124 | 1,089 | 1,108 | -12 | -1.1% | 1,161,000 |
2013/11/18 | 1,120 | 1,124 | 1,110 | 1,120 | +4 | +0.4% | 774,000 |
2013/11/15 | 1,117 | 1,118 | 1,099 | 1,116 | +16 | +1.5% | 1,008,000 |
2013/11/14 | 1,091 | 1,112 | 1,084 | 1,100 | +8 | +0.7% | 1,173,000 |
2013/11/13 | 1,079 | 1,098 | 1,070 | 1,092 | +5 | +0.5% | 1,439,000 |
2013/11/12 | 1,062 | 1,088 | 1,057 | 1,087 | +24 | +2.3% | 1,035,000 |
2013/11/11 | 1,060 | 1,066 | 1,043 | 1,063 | +17 | +1.6% | 896,000 |
2013/11/08 | 1,043 | 1,053 | 1,042 | 1,046 | -14 | -1.3% | 734,000 |
2013/11/07 | 1,058 | 1,066 | 1,058 | 1,060 | +1 | +0.1% | 640,000 |
2013/11/06 | 1,042 | 1,065 | 1,039 | 1,059 | +12 | +1.1% | 731,000 |
2013/11/05 | 1,065 | 1,071 | 1,041 | 1,047 | -10 | -0.9% | 980,000 |
2013/11/01 | 1,079 | 1,080 | 1,051 | 1,057 | -26 | -2.4% | 1,092,000 |
2013/10/31 | 1,061 | 1,088 | 1,061 | 1,083 | +33 | +3.1% | 1,880,000 |
2013/10/30 | 1,050 | 1,056 | 1,043 | 1,050 | +5 | +0.5% | 1,215,000 |
2013/10/29 | 1,035 | 1,049 | 1,033 | 1,045 | +3 | +0.3% | 723,000 |
2013/10/28 | 1,036 | 1,042 | 1,025 | 1,042 | +17 | +1.7% | 648,000 |
2013/10/25 | 1,067 | 1,067 | 1,025 | 1,025 | -45 | -4.2% | 1,284,000 |
2013/10/24 | 1,053 | 1,072 | 1,047 | 1,070 | +4 | +0.4% | 869,000 |
2013/10/23 | 1,079 | 1,084 | 1,066 | 1,066 | -4 | -0.4% | 1,444,000 |
2013/10/22 | 1,083 | 1,083 | 1,061 | 1,070 | -12 | -1.1% | 1,091,000 |
2013/10/21 | 1,060 | 1,082 | 1,060 | 1,082 | +23 | +2.2% | 753,000 |
2013/10/18 | 1,070 | 1,071 | 1,051 | 1,059 | -6 | -0.6% | 1,205,000 |
2013/10/17 | 1,055 | 1,065 | 1,054 | 1,065 | +24 | +2.3% | 748,000 |
2013/10/16 | 1,042 | 1,050 | 1,036 | 1,041 | ±0 | ±0% | 616,000 |
2013/10/15 | 1,051 | 1,058 | 1,037 | 1,041 | -9 | -0.9% | 989,000 |
2013/10/11 | 1,049 | 1,060 | 1,029 | 1,050 | +22 | +2.1% | 1,733,000 |
2013/10/10 | 1,002 | 1,028 | 1,002 | 1,028 | +25 | +2.5% | 898,000 |
2013/10/09 | 990 | 1,004 | 986 | 1,003 | +4 | +0.4% | 1,021,000 |
2013/10/08 | 990 | 1,002 | 985 | 999 | +7 | +0.7% | 1,199,000 |
2013/10/07 | 1,006 | 1,007 | 991 | 992 | -9 | -0.9% | 959,000 |
2013/10/04 | 999 | 1,013 | 995 | 1,001 | +1 | +0.1% | 975,000 |
2013/10/03 | 1,002 | 1,011 | 999 | 1,000 | -1 | -0.1% | 1,098,000 |
2013/10/02 | 1,007 | 1,008 | 997 | 1,001 | -7 | -0.7% | 1,858,000 |
2013/10/01 | 1,010 | 1,019 | 1,006 | 1,008 | ±0 | ±0% | 644,000 |
2013/09/30 | 1,015 | 1,015 | 1,000 | 1,008 | -7 | -0.7% | 851,000 |
2013/09/27 | 1,024 | 1,028 | 1,011 | 1,015 | -9 | -0.9% | 798,000 |
2013/09/26 | 1,012 | 1,024 | 996 | 1,024 | +12 | +1.2% | 881,000 |
2013/09/25 | 1,028 | 1,028 | 1,011 | 1,012 | -3 | -0.3% | 904,000 |
2013/09/24 | 1,008 | 1,019 | 1,007 | 1,015 | -3 | -0.3% | 752,000 |
2013/09/20 | 1,012 | 1,019 | 1,010 | 1,018 | +12 | +1.2% | 1,058,000 |
2013/09/19 | 1,004 | 1,007 | 997 | 1,006 | +7 | +0.7% | 1,154,000 |
2013/09/18 | 1,002 | 1,005 | 993 | 999 | +8 | +0.8% | 1,045,000 |
2013/09/17 | 1,004 | 1,005 | 990 | 991 | -3 | -0.3% | 791,000 |
2013/09/13 | 1,004 | 1,004 | 980 | 994 | -16 | -1.6% | 2,952,000 |
2013/09/12 | 1,012 | 1,012 | 1,003 | 1,010 | +4 | +0.4% | 1,124,000 |
2013/09/11 | 1,017 | 1,024 | 1,003 | 1,006 | -3 | -0.3% | 1,403,000 |
2013/09/10 | 1,008 | 1,014 | 999 | 1,009 | -16 | -1.6% | 1,801,000 |
2013/09/09 | 1,020 | 1,027 | 1,012 | 1,025 | +32 | +3.2% | 998,000 |
2801~
2850
件表示中 / 3697件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 218,300円 | -3.5% | -11.3% | 2.75% | 20.05倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 220,800円 | +20.9% | +10.6% | 2.99% | 10.44倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 390,300円 | +1.7% | -2.9% | 4.10% | 25.61倍 | 1.35倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 150,200円 | +0.6% | +43.3% | 5.33% | 10.53倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 217,800円 | +18.2% | +4.2% | 1.65% | 15.28倍 | 1.94倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム